Literature DB >> 11796822

Functional distinction between CXC chemokines, interleukin-8 (IL-8), and growth related oncogene (GRO)alpha in neutrophil infiltration.

Kazunori Fujiwara1, Akihiro Matsukawa, Susumu Ohkawara, Katsumasa Takagi, Masaru Yoshinaga.   

Abstract

Interleukin-8 (IL-8: CXCL8) and growth related oncogene alpha (GROalpha: CXCL1) are members of the CXC chemokines. In the present study, we explored the functional distinction between these CXC chemokines in the regulation of neutrophil infiltration. Injection of either rabbit IL-8 or GROalpha (10 microg each) into rabbit knee joints resulted in a massive neutrophil infiltration in the joints. At their peak time point (6 hours), the number of neutrophils induced by IL-8 was more than that induced by GROalpha. Each chemokine induced the other chemokine in the joints. TNFalpha activity was induced in the joints after administration of GROalpha, but not IL-8. Treatment with anti-GROalpha mAb and/or anti-TNFalpha mAb failed to inhibit IL-8-induced neutrophil infiltration. In contrast, either anti-IL-8 IgG or anti-TNFalpha mAb decreased GROalpha-induced response, and the inhibition was further enhanced by coadministration of these antibodies. Thus, it appears that IL-8 acts directly, whereas GROalpha acts indirectly, in part, on neutrophil infiltration. The distinct difference in TNFalpha production between IL-8 and GROalpha was further investigated. In vitro, GROalpha induced TNFalpha activity in cultured synovial cells, the cells producing TNFalpha in the joints after GROalpha-injection. However, IL-8 failed to produce TNFalpha activity from the cells, although equivalent levels of the mRNA expression were induced by IL-8 as compared with GROalpha. When recombinant rabbit TNFalpha was incubated with synovial fluids obtained at 2 hours after IL-8 injection, the resultant TNFalpha activity was significantly decreased, an event that was completely restored by a serine protease inhibitor, phenylmethylsulphonyl fluoride (PMSF). Furthermore, TNFalpha activity was unveiled in the joints when IL-8 was intra-articularly injected with PMSF. These data suggest that TNFalpha is degraded by serine protease(s) in the case of IL-8. Taken together, the data clearly demonstrate the functional distinction between IL-8 and GROalpha, which may influence the inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796822     DOI: 10.1038/labinvest.3780391

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 3.  CXCL12: a new player in coronary disease identified through human genetics.

Authors:  Samira S Farouk; Daniel J Rader; Muredach P Reilly; Nehal N Mehta
Journal:  Trends Cardiovasc Med       Date:  2010-08       Impact factor: 6.677

Review 4.  Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.

Authors:  Nasser Chegini
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

5.  P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia.

Authors:  Bernt van den Blink; Judith Branger; Sebastiaan Weijer; Abhya Gupta; Sander J H van Deventer; Maikel P Peppelenbosch; Tom van der Poll
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

6.  The effect of infliximab on chemokines in patients with rheumatoid arthritis.

Authors:  Eiji Torikai; Yasunori Kageyama; Motohiro Suzuki; Tetsuya Ichikawa; Akira Nagano
Journal:  Clin Rheumatol       Date:  2006-11-17       Impact factor: 3.650

7.  c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.

Authors:  Hannah K Drescher; Fabienne Schumacher; Teresa Schenker; Maike Baues; Twan Lammers; Thomas Hieronymus; Christian Trautwein; Konrad L Streetz; Daniela C Kroy
Journal:  Oxid Med Cell Longev       Date:  2018-11-12       Impact factor: 6.543

Review 8.  Matrix metalloproteinases: old dogs with new tricks.

Authors:  Robert P T Somerville; Samantha A Oblander; Suneel S Apte
Journal:  Genome Biol       Date:  2003-05-29       Impact factor: 13.583

Review 9.  MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  Front Immunol       Date:  2015-07-21       Impact factor: 7.561

Review 10.  Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes.

Authors:  Marie Wiedemann; David Voehringer
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.